The immunophilin FKBP12 inhibits hepcidin expression by binding the BMP type I receptor ALK2 in hepatocytes.

about

The immunophilin FKBP12 inhibits hepcidin expression by binding the BMP type I receptor ALK2 in hepatocytes.

Item

http://www.wikidata.org/entity/Q47867384

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

The immunophilin FKBP12 inhibi ...... receptor ALK2 in hepatocytes.

@en

The immunophilin FKBP12 inhibi ...... receptor ALK2 in hepatocytes.

@nl

type

Item

label

The immunophilin FKBP12 inhibi ...... receptor ALK2 in hepatocytes.

@en

The immunophilin FKBP12 inhibi ...... receptor ALK2 in hepatocytes.

@nl

prefLabel

The immunophilin FKBP12 inhibi ...... receptor ALK2 in hepatocytes.

@en

The immunophilin FKBP12 inhibi ...... receptor ALK2 in hepatocytes.

@nl

P1476

The immunophilin FKBP12 inhibi ...... I receptor ALK2 in hepatocytes

@en

P2093

Alessia Pagani

http://www.w3.org/2001/XMLSchema#string

Clara Camaschella

http://www.w3.org/2001/XMLSchema#string

Irene Artuso

http://www.w3.org/2001/XMLSchema#string

Mariateresa Pettinato

http://www.w3.org/2001/XMLSchema#string

P2860

Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization

Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA)

Hemojuvelin regulates hepcidin expression via a selective subset of BMP ligands and receptors independently of neogenin

BMP-2/4 and BMP-6/7 differentially utilize cell surface receptors to induce osteoblastic differentiation of human bone marrow-derived mesenchymal stem cells

USP15 is a deubiquitylating enzyme for receptor-activated SMADs

Structure of the bone morphogenetic protein receptor ALK2 and implications for fibrodysplasia ossificans progressiva

Iron-dependent regulation of hepcidin in Hjv-/- mice: evidence that hemojuvelin is dispensable for sensing body iron levels

Solution structure of a neurotrophic ligand bound to FKBP12 and its effects on protein dynamics

The TGF beta receptor activation process: an inhibitor- to substrate-binding switch

Design and structure-based study of new potential FKBP12 inhibitors

P304

2111-2120

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2017-04-780692

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

130

http://www.w3.org/2001/XMLSchema#string

P50

Laura Silvestri

Antonella Nai

Silvia Colucci

P577

2017-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28864813

http://www.w3.org/2001/XMLSchema#string

P932

5755682

http://www.w3.org/2001/XMLSchema#string